Date01/26/2009AuthorHiddenSourceRBCPreserved copyInternet ArchiveOriginal MaterialShow translationPfizer намерена приобрести конкурента за $67 млрдOur archive does not currently contain the full version of this documentWhere to read:Preserved copyLink to original version
